Accelerate Time to Market: Why it’s Essential to Select the Correct Primary Packaging for Your Formulation at the Earliest Stages of Development

Synopsis

A comprehensive look at how your choice of primary packaging can impact time to market.

We start by covering the minimum requirements for primary parenteral drug packaging – ensuring that the packaging that comes into direct contact with your formulation meets standards set out in the EP, JP and USP.

From there we talk about specific challenges faced by those in drug development, including problems with freeze drying, formulation sensitivities, conforming to the principles of Annex 1, and the part packaging plays in both the problem and the solution.

We provide a guide to the possible solutions, all presented in an informative presentation.